Independent Innovation Accelerates Technological Breakthroughs; SSE STAR Market-Listed "Core Technology" Companies Gain Growing Global Influence
Translated from Shanghai Securities News, He Xinyi
In the context of intensified global trade tensions and technology barriers, SSE STAR Market-listed companies are independently innovating to overcome challenges in the international market. From chip design to biomedicine, and from high-end equipment to new energy, a number of SSE STAR Market-listed companies are facing challenges head-on with technology exports, positioning themselves as pioneers in the upstream of the international value chain.
Technology Exports Breaking Trade Barriers
SSE STAR Market-listed companies maintain an innovation-driven approach, exporting "Chinese solutions" through their independently developed core technologies. Verisilicon Microelectronics (Shanghai) Co., Ltd., the only domestic semiconductor IP supplier among the global top ten, has seen its neural network processing unit IP (NPU IP) adopted by 82 customers across 142 AI chips, while its graphics processing unit IP (GPU IP) has also been widely utilized in data centers and automotive electronics. Shanghai United Imaging Healthcare Co., Ltd. has disrupted the multinational monopoly on medical imaging equipment, with its 5.0T whole-body MRI system becoming the only clinical MRI device globally to receive NMPA, FDA, and CE certifications. Supcon Technology Co., Ltd. has built a global network, achieving breakthroughs in overseas businesses in 2024. It has won the contract for the seawater desalination project control system in Saudi Arabia and delivered a wireless temperature and vibration monitoring system for Switzerland's Holcim, as well as executed the first order of the general control system Nyx in Sweden, reshaping the international competitive landscape with smart manufacturing.
Improving from Internal to External to Withstand Trade Risks
Facing geopolitical fluctuations, SSE STAR Market-listed companies are expanding production overseas, diversifying markets, and integrating capital to enhance supply chain resilience. In 2024, Jinko Solar Co., Ltd., Trina Solar Co., Ltd., and CSI Solar Co., Ltd. ranked among the top in the world in terms of PV module shipments. The PV production has shifted towards a "global manufacturing" model, with Trina Solar Co., Ltd.'s factory in Indonesia showing relative competitive advantages and Jinko Solar Co., Ltd. serving clients in nearly 200 countries and regions. Mergers and acquisitions of high-quality overseas assets are enabling companies to "overtake on the curve." For example, ZWSOFT CO., LTD. (Guangzhou) acquired CHAM fusion technology and released the first Zwsoft fluid simulation software; Halo Microelectronics Co., Ltd.'s takeover of Zinitix in ROK has resulted in successful connections with over 50 global customer relationships and 159 intellectual property rights.
Continuously Rising Global Influence
As globalization deepens and technological competition intensifies, the power to set standards has become a focal point of contention. SSE STAR Market-listed companies have transformed from a standard "follower" to a "leader". For example, Montage Technology Co., Ltd. took the lead in formulating three international standards for memory interface chips. Zhuzhou CRRC Times Electric Co., Ltd. participated in the formulation of 50 international rail transit standards, and Xi'an High Voltage Apparatus Research Institute Co., Ltd. participated in the formulation of more than 40 international standards for power equipment, including 3 insulator technical standards led by China. In life health, 10 pharmaceutical companies have authorized product patents in the form of license-out. Sichuan Biokin Pharmaceutical Co., Ltd will grant Bristol-Myers Squibb the rights of its investigational drug BL-B01D1, with a potential transaction volume of up to USD 8.4 billion. After licensing its toripalimab, Shanghai Junshi Biosciences Co., Ltd. has gained approval for a nasopharyngeal carcinoma indication in the United States.
The above information is provided for reference purposes only and does not constitute investment advice.